Purpose: There are currently no standardized evaluations of longitudinal outcomes for Addiction Medicine Intensive Outpatient Programs (AMIOPs) in the military. At William Beaumont Army Medical Center (WBAMC) in Fort Bliss Texas, the first AMIOP program was introduced in July 2017. AMIOPs are designed to bridge the gap between Residential Treatment Facilities (RTF) and outpatient care provided at Substance Abuse Disorder Clinical Care (SUDCC). The purpose of this project was to evaluate the effectiveness of the AMIOP at meeting the intended treatment and program outcomes at WBAMC.
Design: A retrospective chart review of 76 charts purposely selected from 131 of charts. The charts were a sampling of patients enrolled in the Fort Bliss AMIOP between the dates of August 2017 to August 2018.
Methodology: The program outcomes were measure by successful program completion, re-admission to AMIOP, referral to a RTF, sobriety maintained for 6 months post program completion, continued engagement in a 12-Step community support, continued SUDCC outpatient aftercare.
Conclusion: AMIOP treatment was a major factor in 86 percent of active duty Service Members maintaining self-reported sobriety for at least 6 months post program completion positively influencing quality of life and mission readiness. AMIOP level treatment versus an inpatient RTF stay has shown to drastically reduce RTF referrals with an overall cost savings of over 7 million dollars for the Department of Defense (DoD).
Clinical Relevance: The result of this program evaluation provides exciting opportunities for further research and review of AMIOP implementation and utilization throughout the DOD.
This poster was presented at the 32nd annual Psych Congress, held Oct. 3-6, 2019, in San Diego, California.